文献速递基础与转化研究新药、器械与细胞基因治疗研发

再生医学治疗神经系统疾病:再生神经外科能否兑现承诺?

Regenerative medicine for neurological diseases-will regenerative neurosurgery deliver?
PubMed 文献 · BMJ · 2021-06-23

本文综述再生神经外科在帕金森病、肌萎缩侧索硬化、卒中和脊髓损伤中的转化进展,批判性评估细胞移植、神经营养因子和基因治疗策略的原理与挑战。经三十年工具与方法学积累,再生神经外科已具备推进难治性神经疾病治疗的条件。

要点

  • 再生神经外科通过细胞、神经营养因子和基因递送追求修复而非姑息治疗。
  • 胎儿、体细胞和 pluripotent 干细胞来源植入物旨在替代神经元和胶质细胞并提供营养支持。
  • 帕金森病、肌萎缩侧索硬化、卒中和脊髓损伤是当前转化重点。

核心结论

  • 经数十年工具与方法学发展,再生神经外科已具备推进难治性神经疾病治疗的条件。

研究设计与样本

  • 本文为综述,批判性评估再生神经外科的原理、范式和转化进展。

主要发现

  • 过去三十年已将具有推定再生能力的细胞、神经营养因子和基因引入中枢神经系统。
  • 胎儿、体细胞和多能干细胞来源植入物用于替代内源性神经元和胶质细胞类型并提供营养支持。
  • 通过输注和基因治疗的神经营养因子策略旨在保护神经元回路。

临床怎么用

  • 再生神经外科利用中枢神经系统入路来保护、 rejuvenate 或替代被神经疾病不可逆损害的细胞类型。

局限性

  • 相关操作的风险和新神经外科试验的伦理挑战在文中讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Regenerative medicine aspires to transform the future practice of medicine by providing curative, rather than palliative, treatments. Healing the central nervous system (CNS) remains among regenerative medicine's most highly prized but formidable challenges. "Regenerative neurosurgery" provides access to the CNS or its surrounding structures to preserve or restore neurological function. Pioneering efforts over the past three decades have introduced cells, neurotrophins, and genes with putative regenerative capacity into the CNS to combat neurodegenerative, ischemic, and traumatic diseases. In this review we critically evaluate the rationale, paradigms, and translational progress of regenerative neurosurgery, harnessing access to the CNS to protect, rejuvenate, or replace cell types otherwise irreversibly compromised by neurological disease. We discuss the evidence surrounding fetal, somatic, and pluripotent stem cell derived implants to replace endogenous neuronal and glial cell types and provide trophic support. Neurotrophin based strategies via infusions and gene therapy highlight the motivation to preserve neuronal circuits, the complex fidelity of which cannot be readily recreated. We specifically highlight ongoing translational efforts in Parkinson's disease, amyotrophic lateral sclerosis, stroke, and spinal cord injury, using these to illustrate the principles, challenges, and opportunities of regenerative neurosurgery. Risks of associated procedures and novel neurosurgical trials are discussed, together with the ethical challenges they pose. After decades of efforts to develop and refine necessary tools and methodologies, regenerative neurosurgery is well positioned to advance treatments for refractory neurological diseases. Strategic multidisciplinary efforts will be critical to harness complementary technologies and maximize mechanistic feedback, accelerating iterative progress toward cures for neurological diseases.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Burns TC, Quinones-Hinojosa A. Regenerative medicine for neurological diseases-will regenerative neurosurgery deliver? BMJ. 2021. PMID: 34162530. doi:10.1136/bmj.n955

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。